Ingmar Bruns
Chief Medical Officer · 1 filing · Latest: Feb 6, 2026
Zentalis Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
ZNTL | Ingmar Bruns | Chief Medical Officer | Feb 9, 2026 | Sale | $2.39 | 335 | $802 | 33,332 | |
ZNTL | Ingmar Bruns | Chief Medical Officer | Feb 6, 2026 | Sale | $2.43 | 2,962 | $7.2K | 33,667 | |